Kogan.com's estimated fair value is AU$6.87 based on 2 Stage Free Cash Flow to Equity Kogan.com is estimated to be 49% undervalued based on current share price of AU$3.49 Our fair value estimate is 16 ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its ...
The popular restaurant might be required to shore up flood resiliency as it pursues plans to return to St. Armands Circle.
With the SEBI Grade A 2026 Phase 1 exam just days away, success depends on sharp revision, smart question selection, and ...
Real estate businesses concluded 2025 with breakthroughs in business, including projects relaunching on the market. Entering ...
Screen Rant on MSN
Genshin Impact 6.3 livestream: Date, time, characters, banners, & more
The next big update for Genshin Impact, known as Version 6.3, will have its contents showcased during the upcoming livestream ...
ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...
Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...
Is such a pause achievable? Judging by reports from the battlefield, there is currently no clear affirmative answer—but neither is there a definitive negative one. The war has simply moved over from ...
Quantum computing is a promising field with massive long-term potential, but it is still in its early commercialization phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback